urea has been researched along with Cardiovascular Diseases in 61 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of N-acetylcysteine (NAC) to prevent contrast nephropathy (CN) in patients with moderate to severe renal insufficiency undergoing coronary angiography or interventions is not clear." | 9.11 | Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. ( Chan, AK; Chan, JY; Chan, WW; Fung, JW; Kum, LC; Sanderson, JE; Szeto, CC; Wong, JT; Woo, KS; Wu, EB; Yip, GW; Yu, CM, 2004) |
| "The objective of this study was to evaluate the effect of vitamin D3 on total homocysteine (tHcy) and C-reactive protein (CRP) levels and liver and kidney function tests in overweight women with vitamin D deficiency." | 5.41 | Vitamin D ( Al-Bayyari, N; Alkhalidy, H; Eaton, A; Hailat, R; Subih, H, 2021) |
| "The effect of N-acetylcysteine (NAC) to prevent contrast nephropathy (CN) in patients with moderate to severe renal insufficiency undergoing coronary angiography or interventions is not clear." | 5.11 | Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. ( Chan, AK; Chan, JY; Chan, WW; Fung, JW; Kum, LC; Sanderson, JE; Szeto, CC; Wong, JT; Woo, KS; Wu, EB; Yip, GW; Yu, CM, 2004) |
| "04), urinary urea nitrogen and proteinuria (P<0." | 5.10 | Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. ( Atabak, S; Azadbakht, L; Esmaill-Zadeh, A; Jamshidian, M; Mehrabi, Y; Shakerhosseini, R, 2003) |
| " Hematocrit, urea, creatinine and microalbuminuria were analyzed, after which the HUGE formula was applied." | 3.81 | The H.U.G.E. Formula (Hematocrit, Urea, Sex) for Screening Chronic Kidney Disease (CKD) in an Age-Stratified General Population. ( Felix, FJ; Fernandez-Berges, D; Lozano, L; Macías, JF; Miranda, I; Robles, NR, 2015) |
| "High plasma uric acid (UA) is a prerequisite for gout and is also associated with the metabolic syndrome and its components and consequently risk factors for cardiovascular diseases." | 3.79 | Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. ( Burini, RC; de Oliveira, EP; Moreto, F; Silveira, LV, 2013) |
| "Labetalol has been studied to a lesser extent and may have prolonged cardiovascular effects." | 2.50 | Beta-blocking agents during electroconvulsive therapy: a review. ( Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW, 2014) |
| "Hyperphosphatemia is highly prevalent in hemodialysis (HD) and peritoneal dialysis (PD) patients and is a major risk factor for cardiovascular mortality." | 2.46 | Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. ( Kuhlmann, MK, 2010) |
| "Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world." | 2.46 | Cardiovascular pharmacology: an update. ( Fox, CJ; Kaye, AD; Liu, H; Zhang, S, 2010) |
| "Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood." | 1.56 | Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank. ( Allen, NE; Andrews, C; Fensom, GK; Key, TJ; Martin, RM; Perez-Cornago, A; Travis, RC; Van Hemelrijck, M; Watts, EL, 2020) |
| "Cardiovascular and kidney diseases are a global public health problem and impose a huge economic burden on health care services." | 1.37 | Simultaneous, noninvasive, and transdermal extraction of urea and homocysteine by reverse iontophoresis. ( Ching, CT; Chou, TR; Huang, SY; Shieh, HL; Sun, TP, 2011) |
| " In conclusion, our study suggests that chronic administration of celecoxib may have a damaging effect on kidney, as evident through altered histopathology and renal functions." | 1.34 | Role of oxidative stress in celecoxib-induced renal damage in wistar rats. ( Aggarwal, R; Agnihotri, N; Dutta, N; Gupta, S; Sarotra, P, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (11.48) | 18.7374 |
| 1990's | 2 (3.28) | 18.2507 |
| 2000's | 15 (24.59) | 29.6817 |
| 2010's | 27 (44.26) | 24.3611 |
| 2020's | 10 (16.39) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Hamid, DZ | 1 |
| Nienaa, YA | 1 |
| Mostafa, TM | 1 |
| Colombo, G | 1 |
| Altomare, A | 1 |
| Astori, E | 1 |
| Landoni, L | 1 |
| Garavaglia, ML | 1 |
| Rossi, R | 1 |
| Giustarini, D | 1 |
| Lionetti, MC | 1 |
| Gagliano, N | 1 |
| Milzani, A | 1 |
| Dalle-Donne, I | 1 |
| Haberman, D | 1 |
| Chernin, G | 1 |
| Meledin, V | 1 |
| Zikry, M | 1 |
| Shuvy, M | 2 |
| Gandelman, G | 1 |
| Goland, S | 2 |
| George, J | 1 |
| Shimoni, S | 1 |
| Al-Bayyari, N | 1 |
| Hailat, R | 1 |
| Subih, H | 1 |
| Alkhalidy, H | 1 |
| Eaton, A | 1 |
| Du, Q | 1 |
| Gao, J | 1 |
| Lu, R | 1 |
| Jin, Y | 1 |
| Zou, Y | 1 |
| Yu, C | 1 |
| Yan, Y | 1 |
| Romão da Silva, LF | 1 |
| de Oliveira, Y | 1 |
| de Souza, EL | 1 |
| de Luna Freire, MO | 1 |
| Braga, VA | 1 |
| Magnani, M | 1 |
| de Brito Alves, JL | 1 |
| Nguépy Keubo, FR | 1 |
| Mboua, PC | 1 |
| Djifack Tadongfack, T | 1 |
| Fokouong Tchoffo, E | 1 |
| Tasson Tatang, C | 1 |
| Ide Zeuna, J | 1 |
| Noupoue, EM | 1 |
| Tsoplifack, CB | 1 |
| Folefack, GO | 1 |
| Kettani, M | 1 |
| Bandelier, P | 1 |
| Huo, J | 1 |
| Li, H | 4 |
| Yu, D | 1 |
| Arulsamy, N | 1 |
| AlAbbad, S | 1 |
| Sardot, T | 1 |
| Lekashvili, O | 1 |
| Decato, D | 1 |
| Lelj, F | 1 |
| Alexander Ross, JB | 1 |
| Rosenberg, E | 1 |
| Nazir, H | 1 |
| Muthuswamy, N | 1 |
| Louis, C | 1 |
| Jose, S | 1 |
| Prakash, J | 1 |
| Buan, MEM | 1 |
| Flox, C | 1 |
| Chavan, S | 1 |
| Shi, X | 1 |
| Kauranen, P | 1 |
| Kallio, T | 1 |
| Maia, G | 1 |
| Tammeveski, K | 1 |
| Lymperopoulos, N | 1 |
| Carcadea, E | 1 |
| Veziroglu, E | 1 |
| Iranzo, A | 1 |
| M Kannan, A | 1 |
| Arunamata, A | 1 |
| Tacy, TA | 1 |
| Kache, S | 1 |
| Mainwaring, RD | 1 |
| Ma, M | 1 |
| Maeda, K | 1 |
| Punn, R | 1 |
| Noguchi, S | 1 |
| Hahn, S | 3 |
| Iwasa, Y | 3 |
| Ling, J | 2 |
| Voccio, JP | 2 |
| Kim, Y | 3 |
| Song, J | 3 |
| Bascuñán, J | 2 |
| Chu, Y | 1 |
| Tomita, M | 1 |
| Cazorla, M | 1 |
| Herrera, E | 1 |
| Palomeque, E | 1 |
| Saud, N | 1 |
| Hoplock, LB | 1 |
| Lobchuk, MM | 1 |
| Lemoine, J | 1 |
| Li, X | 10 |
| Henson, MA | 1 |
| Unsihuay, D | 1 |
| Qiu, J | 1 |
| Swaroop, S | 1 |
| Nagornov, KO | 1 |
| Kozhinov, AN | 1 |
| Tsybin, YO | 1 |
| Kuang, S | 1 |
| Laskin, J | 1 |
| Zin, NNINM | 1 |
| Mohamad, MN | 1 |
| Roslan, K | 1 |
| Abdul Wafi, S | 1 |
| Abdul Moin, NI | 1 |
| Alias, A | 1 |
| Zakaria, Y | 1 |
| Abu-Bakar, N | 1 |
| Naveed, A | 1 |
| Jilani, K | 1 |
| Siddique, AB | 1 |
| Akbar, M | 1 |
| Riaz, M | 1 |
| Mushtaq, Z | 1 |
| Sikandar, M | 1 |
| Ilyas, S | 1 |
| Bibi, I | 1 |
| Asghar, A | 1 |
| Rasool, G | 1 |
| Irfan, M | 1 |
| Li, XY | 1 |
| Zhao, S | 1 |
| Fan, XH | 1 |
| Chen, KP | 1 |
| Hua, W | 1 |
| Liu, ZM | 1 |
| Xue, XD | 1 |
| Zhou, B | 1 |
| Zhang, S | 3 |
| Xing, YL | 1 |
| Chen, MA | 1 |
| Sun, Y | 2 |
| Neradilek, MB | 1 |
| Wu, XT | 1 |
| Zhang, D | 2 |
| Huang, W | 1 |
| Cui, Y | 1 |
| Yang, QQ | 1 |
| Li, HW | 1 |
| Zhao, XQ | 1 |
| Hossein Rashidi, B | 1 |
| Tarafdari, A | 1 |
| Ghazimirsaeed, ST | 1 |
| Shahrokh Tehraninezhad, E | 1 |
| Keikha, F | 1 |
| Eslami, B | 1 |
| Ghazimirsaeed, SM | 1 |
| Jafarabadi, M | 1 |
| Silvani, Y | 1 |
| Lovita, AND | 1 |
| Maharani, A | 1 |
| Wiyasa, IWA | 1 |
| Sujuti, H | 1 |
| Ratnawati, R | 1 |
| Raras, TYM | 1 |
| Lemin, AS | 1 |
| Rahman, MM | 1 |
| Pangarah, CA | 1 |
| Kiyu, A | 1 |
| Zeng, C | 2 |
| Du, H | 1 |
| Lin, D | 1 |
| Jalan, D | 1 |
| Rubagumya, F | 1 |
| Hopman, WM | 1 |
| Vanderpuye, V | 1 |
| Lopes, G | 1 |
| Seruga, B | 1 |
| Booth, CM | 1 |
| Berry, S | 1 |
| Hammad, N | 1 |
| Sajo, EA | 1 |
| Okunade, KS | 1 |
| Olorunfemi, G | 1 |
| Rabiu, KA | 1 |
| Anorlu, RI | 1 |
| Xu, C | 2 |
| Xiang, Y | 1 |
| Xu, X | 1 |
| Zhou, L | 2 |
| Dong, X | 1 |
| Tang, S | 1 |
| Gao, XC | 1 |
| Wei, CH | 1 |
| Zhang, RG | 1 |
| Cai, Q | 1 |
| He, Y | 1 |
| Tong, F | 1 |
| Dong, JH | 1 |
| Wu, G | 1 |
| Dong, XR | 1 |
| Tang, X | 1 |
| Tao, F | 1 |
| Xiang, W | 1 |
| Zhao, Y | 2 |
| Jin, L | 1 |
| Tao, H | 1 |
| Lei, Y | 1 |
| Gan, H | 1 |
| Huang, Y | 1 |
| Chen, Y | 3 |
| Chen, L | 3 |
| Shan, A | 1 |
| Zhao, H | 2 |
| Wu, M | 2 |
| Ma, Q | 1 |
| Wang, J | 4 |
| Zhang, E | 1 |
| Zhang, J | 3 |
| Li, Y | 5 |
| Xue, F | 1 |
| Deng, L | 1 |
| Liu, L | 2 |
| Yan, Z | 2 |
| Wang, Y | 2 |
| Meng, J | 1 |
| Chen, G | 2 |
| Anastassiadou, M | 1 |
| Bernasconi, G | 1 |
| Brancato, A | 1 |
| Carrasco Cabrera, L | 1 |
| Greco, L | 1 |
| Jarrah, S | 1 |
| Kazocina, A | 1 |
| Leuschner, R | 1 |
| Magrans, JO | 1 |
| Miron, I | 1 |
| Nave, S | 1 |
| Pedersen, R | 1 |
| Reich, H | 1 |
| Rojas, A | 1 |
| Sacchi, A | 1 |
| Santos, M | 1 |
| Theobald, A | 1 |
| Vagenende, B | 1 |
| Verani, A | 1 |
| Du, L | 1 |
| Liu, X | 1 |
| Ren, Y | 1 |
| Li, J | 8 |
| Li, P | 1 |
| Jiao, Q | 1 |
| Meng, P | 1 |
| Wang, F | 2 |
| Wang, YS | 1 |
| Wang, C | 3 |
| Zhou, X | 2 |
| Wang, W | 1 |
| Wang, S | 2 |
| Hou, J | 1 |
| Zhang, A | 1 |
| Lv, B | 1 |
| Gao, C | 1 |
| Pang, D | 1 |
| Lu, K | 1 |
| Ahmad, NH | 1 |
| Wang, L | 2 |
| Zhu, J | 2 |
| Zhang, L | 2 |
| Zhuang, T | 1 |
| Tu, J | 1 |
| Zhao, Z | 1 |
| Qu, Y | 1 |
| Yao, H | 1 |
| Wang, X | 5 |
| Lee, DF | 1 |
| Shen, J | 3 |
| Wen, L | 1 |
| Huang, G | 2 |
| Xie, X | 1 |
| Zhao, Q | 1 |
| Hu, W | 1 |
| Zhang, Y | 4 |
| Wu, X | 1 |
| Lu, J | 2 |
| Li, M | 1 |
| Li, W | 2 |
| Wu, W | 1 |
| Du, F | 1 |
| Ji, H | 1 |
| Yang, X | 2 |
| Xu, Z | 1 |
| Wan, L | 1 |
| Wen, Q | 1 |
| Cho, CH | 1 |
| Zou, C | 1 |
| Xiao, Z | 1 |
| Liao, J | 1 |
| Su, X | 1 |
| Bi, Z | 1 |
| Su, Q | 1 |
| Huang, H | 1 |
| Wei, Y | 2 |
| Gao, Y | 2 |
| Na, KJ | 1 |
| Choi, H | 1 |
| Oh, HR | 1 |
| Kim, YH | 1 |
| Lee, SB | 1 |
| Jung, YJ | 1 |
| Koh, J | 1 |
| Park, S | 1 |
| Lee, HJ | 1 |
| Jeon, YK | 1 |
| Chung, DH | 1 |
| Paeng, JC | 1 |
| Park, IK | 1 |
| Kang, CH | 1 |
| Cheon, GJ | 1 |
| Kang, KW | 1 |
| Lee, DS | 1 |
| Kim, YT | 1 |
| Pajuelo-Lozano, N | 1 |
| Alcalá, S | 1 |
| Sainz, B | 1 |
| Perona, R | 1 |
| Sanchez-Perez, I | 1 |
| Logotheti, S | 1 |
| Marquardt, S | 1 |
| Gupta, SK | 1 |
| Richter, C | 1 |
| Edelhäuser, BAH | 1 |
| Engelmann, D | 1 |
| Brenmoehl, J | 1 |
| Söhnchen, C | 1 |
| Murr, N | 1 |
| Alpers, M | 1 |
| Singh, KP | 1 |
| Wolkenhauer, O | 1 |
| Heckl, D | 1 |
| Spitschak, A | 1 |
| Pützer, BM | 1 |
| Liao, Y | 1 |
| Cheng, J | 1 |
| Kong, X | 1 |
| Li, S | 1 |
| Zhang, M | 4 |
| Zhang, H | 1 |
| Yang, T | 2 |
| Dong, Y | 1 |
| Xu, Y | 1 |
| Yuan, Z | 1 |
| Cao, J | 1 |
| Zheng, Y | 1 |
| Luo, Z | 1 |
| Mei, Z | 1 |
| Yao, Y | 1 |
| Liu, Z | 2 |
| Liang, C | 1 |
| Yang, H | 1 |
| Song, Y | 1 |
| Yu, K | 1 |
| Zhu, C | 1 |
| Huang, Z | 1 |
| Qian, J | 1 |
| Ge, J | 1 |
| Hu, J | 2 |
| Wang, H | 2 |
| Liu, Y | 4 |
| Mi, Y | 1 |
| Kong, H | 1 |
| Xi, D | 1 |
| Yan, W | 1 |
| Luo, X | 1 |
| Ning, Q | 1 |
| Chang, X | 2 |
| Zhang, T | 2 |
| Wang, Q | 2 |
| Rathore, MG | 1 |
| Reddy, K | 1 |
| Chen, H | 1 |
| Shin, SH | 1 |
| Ma, WY | 1 |
| Bode, AM | 1 |
| Dong, Z | 1 |
| Mu, W | 1 |
| Liu, C | 3 |
| Gao, F | 1 |
| Qi, Y | 1 |
| Lu, H | 1 |
| Zhang, X | 4 |
| Cai, X | 2 |
| Ji, RY | 1 |
| Hou, Y | 3 |
| Tian, J | 2 |
| Shi, Y | 1 |
| Ying, S | 1 |
| Tan, M | 1 |
| Feng, G | 1 |
| Kuang, Y | 1 |
| Chen, D | 1 |
| Wu, D | 3 |
| Zhu, ZQ | 1 |
| Tang, HX | 1 |
| Shi, ZE | 1 |
| Kang, J | 1 |
| Liu, Q | 1 |
| Qi, J | 2 |
| Mu, J | 1 |
| Cong, Z | 1 |
| Chen, S | 2 |
| Fu, D | 1 |
| Li, Z | 2 |
| Celestrin, CP | 1 |
| Rocha, GZ | 1 |
| Stein, AM | 1 |
| Guadagnini, D | 1 |
| Tadelle, RM | 1 |
| Saad, MJA | 1 |
| Oliveira, AG | 1 |
| Bianconi, V | 1 |
| Bronzo, P | 1 |
| Banach, M | 1 |
| Sahebkar, A | 1 |
| Mannarino, MR | 1 |
| Pirro, M | 1 |
| Patsourakos, NG | 1 |
| Kouvari, M | 1 |
| Kotidis, A | 1 |
| Kalantzi, KI | 1 |
| Tsoumani, ME | 1 |
| Anastasiadis, F | 1 |
| Andronikos, P | 1 |
| Aslanidou, T | 1 |
| Efraimidis, P | 1 |
| Georgiopoulos, A | 1 |
| Gerakiou, K | 1 |
| Grigoriadou-Skouta, E | 1 |
| Grigoropoulos, P | 1 |
| Hatzopoulos, D | 1 |
| Kartalis, A | 1 |
| Lyras, A | 1 |
| Markatos, G | 1 |
| Mikrogeorgiou, A | 1 |
| Myroforou, I | 1 |
| Orkopoulos, A | 1 |
| Pavlidis, P | 1 |
| Petras, C | 1 |
| Riga, M | 1 |
| Skouloudi, M | 1 |
| Smyrnioudis, N | 1 |
| Thomaidis, K | 1 |
| Tsikouri, GE | 1 |
| Tsikouris, EI | 1 |
| Zisimos, K | 1 |
| Vavoulis, P | 1 |
| Vitali, MG | 1 |
| Vitsas, G | 1 |
| Vogiatzidis, C | 1 |
| Chantanis, S | 1 |
| Fousas, S | 1 |
| Panagiotakos, DB | 1 |
| Tselepis, AD | 1 |
| Jungen, C | 1 |
| Alken, FA | 1 |
| Eickholt, C | 1 |
| Scherschel, K | 1 |
| Kuklik, P | 1 |
| Klatt, N | 1 |
| Schwarzl, J | 1 |
| Moser, J | 1 |
| Jularic, M | 1 |
| Akbulak, RO | 1 |
| Schaeffer, B | 1 |
| Willems, S | 1 |
| Meyer, C | 1 |
| Nowak, JK | 1 |
| Szczepanik, M | 1 |
| Trypuć, M | 1 |
| Pogorzelski, A | 1 |
| Bobkowski, W | 1 |
| Grytczuk, M | 1 |
| Minarowska, A | 1 |
| Wójciak, R | 1 |
| Walkowiak, J | 1 |
| Lu, Y | 1 |
| Xi, J | 1 |
| Li, C | 1 |
| Chen, W | 2 |
| Hu, X | 1 |
| Zhang, F | 1 |
| Wei, H | 1 |
| Wang, Z | 1 |
| Gurzu, S | 1 |
| Jung, I | 1 |
| Sugimura, H | 2 |
| Stefan-van Staden, RI | 1 |
| Yamada, H | 1 |
| Natsume, H | 1 |
| Iwashita, Y | 1 |
| Szodorai, R | 1 |
| Szederjesi, J | 1 |
| Yari, D | 1 |
| Ehsanbakhsh, Z | 1 |
| Validad, MH | 1 |
| Langroudi, FH | 1 |
| Esfandiari, H | 1 |
| Prager, A | 1 |
| Hassanpour, K | 1 |
| Kurup, SP | 1 |
| Mets-Halgrimson, R | 1 |
| Yoon, H | 1 |
| Zeid, JL | 1 |
| Mets, MB | 1 |
| Rahmani, B | 1 |
| Araujo-Castillo, RV | 1 |
| Culquichicón, C | 1 |
| Solis Condor, R | 1 |
| Efendi, F | 1 |
| Sebayang, SK | 1 |
| Astutik, E | 1 |
| Hadisuyatmana, S | 1 |
| Has, EMM | 1 |
| Kuswanto, H | 1 |
| Foroutan, T | 1 |
| Ahmadi, F | 1 |
| Moayer, F | 1 |
| Khalvati, S | 1 |
| Zhang, Q | 2 |
| Lyu, Y | 1 |
| Huang, J | 1 |
| Yu, N | 1 |
| Wen, Z | 1 |
| Hou, H | 1 |
| Zhao, T | 1 |
| Gupta, A | 1 |
| Khosla, N | 1 |
| Govindasamy, V | 1 |
| Saini, A | 1 |
| Annapurna, K | 1 |
| Dhakate, SR | 1 |
| Akkaya, Ö | 1 |
| Chandgude, AL | 1 |
| Dömling, A | 1 |
| Harnett, J | 1 |
| Oakes, K | 1 |
| Carè, J | 1 |
| Leach, M | 1 |
| Brown, D | 1 |
| Cramer, H | 1 |
| Pinder, TA | 1 |
| Steel, A | 1 |
| Anheyer, D | 1 |
| Cantu, J | 1 |
| Valle, J | 1 |
| Flores, K | 1 |
| Gonzalez, D | 1 |
| Valdes, C | 1 |
| Lopez, J | 1 |
| Padilla, V | 1 |
| Alcoutlabi, M | 1 |
| Parsons, J | 1 |
| Núñez, K | 1 |
| Hamed, M | 1 |
| Fort, D | 1 |
| Bruce, D | 1 |
| Thevenot, P | 1 |
| Cohen, A | 1 |
| Weber, P | 1 |
| Menezes, AMB | 1 |
| Gonçalves, H | 1 |
| Perez-Padilla, R | 1 |
| Jarvis, D | 1 |
| de Oliveira, PD | 1 |
| Wehrmeister, FC | 1 |
| Mir, S | 1 |
| Wong, J | 1 |
| Ryan, CM | 1 |
| Bellingham, G | 1 |
| Singh, M | 2 |
| Waseem, R | 1 |
| Eckert, DJ | 1 |
| Chung, F | 1 |
| Hegde, H | 1 |
| Shimpi, N | 1 |
| Panny, A | 1 |
| Glurich, I | 1 |
| Christie, P | 1 |
| Acharya, A | 1 |
| English, KL | 1 |
| Downs, M | 1 |
| Goetchius, E | 1 |
| Buxton, R | 1 |
| Ryder, JW | 1 |
| Ploutz-Snyder, R | 1 |
| Guilliams, M | 1 |
| Scott, JM | 1 |
| Ploutz-Snyder, LL | 1 |
| Martens, C | 1 |
| Goplen, FK | 1 |
| Aasen, T | 1 |
| Gjestad, R | 1 |
| Nordfalk, KF | 1 |
| Nordahl, SHG | 1 |
| Inoue, T | 1 |
| Soshi, S | 1 |
| Kubota, M | 1 |
| Marumo, K | 1 |
| Mortensen, NP | 1 |
| Caffaro, MM | 1 |
| Patel, PR | 2 |
| Uddin, MJ | 1 |
| Aravamudhan, S | 1 |
| Sumner, SJ | 1 |
| Fennell, TR | 1 |
| Gal, RL | 1 |
| Cohen, NJ | 1 |
| Kruger, D | 1 |
| Beck, RW | 1 |
| Bergenstal, RM | 1 |
| Calhoun, P | 1 |
| Cushman, T | 1 |
| Haban, A | 1 |
| Hood, K | 1 |
| Johnson, ML | 1 |
| McArthur, T | 1 |
| Olson, BA | 1 |
| Weinstock, RS | 1 |
| Oser, SM | 1 |
| Oser, TK | 1 |
| Bugielski, B | 1 |
| Strayer, H | 1 |
| Aleppo, G | 1 |
| Maruyama, H | 1 |
| Hirayama, K | 1 |
| Yamashita, M | 1 |
| Ohgi, K | 1 |
| Tsujimoto, R | 1 |
| Takayasu, M | 1 |
| Shimohata, H | 1 |
| Kobayashi, M | 1 |
| Buscagan, TM | 1 |
| Rees, DC | 1 |
| Jaborek, JR | 1 |
| Zerby, HN | 1 |
| Wick, MP | 1 |
| Fluharty, FL | 1 |
| Moeller, SJ | 1 |
| Razavi, P | 1 |
| Dickler, MN | 1 |
| Shah, PD | 1 |
| Toy, W | 1 |
| Brown, DN | 1 |
| Won, HH | 1 |
| Li, BT | 1 |
| Shen, R | 1 |
| Vasan, N | 1 |
| Modi, S | 1 |
| Jhaveri, K | 1 |
| Caravella, BA | 1 |
| Patil, S | 1 |
| Selenica, P | 1 |
| Zamora, S | 1 |
| Cowan, AM | 1 |
| Comen, E | 1 |
| Singh, A | 1 |
| Covey, A | 1 |
| Berger, MF | 1 |
| Hudis, CA | 1 |
| Norton, L | 1 |
| Nagy, RJ | 1 |
| Odegaard, JI | 1 |
| Lanman, RB | 1 |
| Solit, DB | 1 |
| Robson, ME | 1 |
| Lacouture, ME | 1 |
| Brogi, E | 1 |
| Reis-Filho, JS | 1 |
| Moynahan, ME | 1 |
| Scaltriti, M | 1 |
| Chandarlapaty, S | 1 |
| Papouskova, K | 1 |
| Moravcova, M | 1 |
| Masrati, G | 1 |
| Ben-Tal, N | 1 |
| Sychrova, H | 1 |
| Zimmermannova, O | 1 |
| Fang, J | 1 |
| Fan, Y | 1 |
| Luo, T | 2 |
| Su, H | 1 |
| Tsetseris, L | 1 |
| Anthopoulos, TD | 1 |
| Liu, SF | 1 |
| Zhao, K | 1 |
| Sacan, O | 1 |
| Turkyilmaz, IB | 1 |
| Bayrak, BB | 1 |
| Mutlu, O | 1 |
| Akev, N | 1 |
| Yanardag, R | 1 |
| Gruber, S | 1 |
| Kamnoedboon, P | 1 |
| Özcan, M | 1 |
| Srinivasan, M | 1 |
| Jo, YH | 1 |
| Oh, HK | 1 |
| Jeong, SY | 1 |
| Lee, BG | 1 |
| Zheng, J | 1 |
| Guan, H | 1 |
| Li, D | 2 |
| Tan, H | 1 |
| Maji, TK | 1 |
| J R, A | 1 |
| Mukherjee, S | 1 |
| Alexander, R | 1 |
| Mondal, A | 1 |
| Das, S | 1 |
| Sharma, RK | 1 |
| Chakraborty, NK | 1 |
| Dasgupta, K | 1 |
| Sharma, AMR | 1 |
| Hawaldar, R | 1 |
| Pandey, M | 1 |
| Naik, A | 1 |
| Majumdar, K | 1 |
| Pal, SK | 1 |
| Adarsh, KV | 1 |
| Ray, SK | 1 |
| Karmakar, D | 1 |
| Ma, Y | 2 |
| Gao, W | 1 |
| Ma, S | 1 |
| Lin, W | 1 |
| Zhou, T | 1 |
| Wu, T | 1 |
| Wu, Q | 1 |
| Ye, C | 1 |
| He, X | 1 |
| Jiang, F | 1 |
| Yuan, D | 1 |
| Chen, Q | 1 |
| Hong, M | 1 |
| Chen, K | 1 |
| Hussain, M | 1 |
| Razi, SS | 1 |
| Yildiz, EA | 1 |
| Zhao, J | 1 |
| Yaglioglu, HG | 1 |
| Donato, MD | 1 |
| Jiang, J | 1 |
| Jamil, MI | 1 |
| Zhan, X | 1 |
| Chen, F | 1 |
| Cheng, D | 1 |
| Wu, CT | 1 |
| Utsunomiya, T | 1 |
| Ichii, T | 1 |
| Fujinami, S | 1 |
| Nakajima, K | 1 |
| Sanchez, DM | 1 |
| Raucci, U | 1 |
| Ferreras, KN | 1 |
| Martínez, TJ | 1 |
| Mordi, NA | 1 |
| Mordi, IR | 1 |
| Singh, JS | 1 |
| McCrimmon, RJ | 1 |
| Struthers, AD | 1 |
| Lang, CC | 1 |
| Wang, XW | 1 |
| Yuan, LJ | 1 |
| Yang, Y | 1 |
| Chen, WF | 1 |
| Luo, R | 1 |
| Yang, K | 1 |
| Amarasiri, SS | 1 |
| Attanayake, AP | 1 |
| Arawwawala, LDAM | 1 |
| Jayatilaka, KAPW | 1 |
| Mudduwa, LKB | 1 |
| Ogunsuyi, O | 2 |
| Akanni, O | 1 |
| Alabi, O | 1 |
| Alimba, C | 1 |
| Adaramoye, O | 1 |
| Cambier, S | 1 |
| Eswara, S | 1 |
| Gutleb, AC | 1 |
| Bakare, A | 1 |
| Gu, Z | 1 |
| Cong, J | 1 |
| Pellegrini, M | 1 |
| Palmieri, S | 1 |
| Ricci, A | 1 |
| Serio, A | 1 |
| Paparella, A | 1 |
| Lo Sterzo, C | 1 |
| Jadeja, SD | 1 |
| Vaishnav, J | 1 |
| Mansuri, MS | 1 |
| Shah, C | 1 |
| Mayatra, JM | 1 |
| Shah, A | 1 |
| Begum, R | 1 |
| Song, H | 2 |
| Lian, Y | 1 |
| Wan, T | 1 |
| Schultz-Lebahn, A | 1 |
| Skipper, MT | 1 |
| Hvas, AM | 1 |
| Larsen, OH | 1 |
| Hijazi, Z | 1 |
| Granger, CB | 1 |
| Hohnloser, SH | 1 |
| Westerbergh, J | 1 |
| Lindbäck, J | 1 |
| Alexander, JH | 1 |
| Keltai, M | 1 |
| Parkhomenko, A | 2 |
| López-Sendón, JL | 1 |
| Lopes, RD | 1 |
| Siegbahn, A | 1 |
| Wallentin, L | 1 |
| El-Tarabany, MS | 1 |
| Saleh, AA | 1 |
| El-Araby, IE | 1 |
| El-Magd, MA | 1 |
| van Ginkel, MPH | 1 |
| Schijven, MP | 1 |
| van Grevenstein, WMU | 1 |
| Schreuder, HWR | 1 |
| Pereira, EDM | 1 |
| da Silva, J | 1 |
| Carvalho, PDS | 1 |
| Grivicich, I | 1 |
| Picada, JN | 1 |
| Salgado Júnior, IB | 1 |
| Vasques, GJ | 1 |
| Pereira, MADS | 1 |
| Reginatto, FH | 1 |
| Ferraz, ABF | 1 |
| Vasilenko, EA | 1 |
| Gorshkova, EN | 1 |
| Astrakhantseva, IV | 1 |
| Drutskaya, MS | 1 |
| Tillib, SV | 1 |
| Nedospasov, SA | 1 |
| Mokhonov, VV | 1 |
| Nam, YW | 1 |
| Cui, M | 1 |
| Orfali, R | 1 |
| Viegas, A | 1 |
| Nguyen, M | 1 |
| Mohammed, EHM | 1 |
| Zoghebi, KA | 1 |
| Rahighi, S | 1 |
| Parang, K | 1 |
| Patterson, KC | 1 |
| Kahanovitch, U | 1 |
| Gonçalves, CM | 1 |
| Hablitz, JJ | 1 |
| Staruschenko, A | 1 |
| Mulkey, DK | 1 |
| Olsen, ML | 1 |
| Gu, L | 1 |
| Cao, X | 1 |
| Mukhtar, A | 1 |
| Wu, K | 1 |
| Zhang, YY | 1 |
| Zhu, Y | 1 |
| Lu, DZ | 1 |
| Dong, W | 1 |
| Bi, WJ | 1 |
| Feng, XJ | 1 |
| Wen, LM | 1 |
| Sun, H | 1 |
| Qi, MC | 1 |
| Chang, CC | 1 |
| Dinh, TK | 1 |
| Lee, YA | 1 |
| Wang, FN | 1 |
| Sung, YC | 1 |
| Yu, PL | 1 |
| Chiu, SC | 1 |
| Shih, YC | 1 |
| Wu, CY | 1 |
| Huang, YD | 1 |
| Lu, TT | 1 |
| Wan, D | 1 |
| Sakizadeh, J | 1 |
| Cline, JP | 1 |
| Snyder, MA | 1 |
| Kiely, CJ | 1 |
| McIntosh, S | 1 |
| Jiang, X | 1 |
| Cao, JW | 1 |
| Zhao, CK | 1 |
| Yang, R | 1 |
| Zhang, QY | 1 |
| Chen, KJ | 2 |
| Liu, H | 2 |
| He, Z | 1 |
| Chen, B | 1 |
| Wu, J | 1 |
| Du, X | 1 |
| Moore, J | 1 |
| Blank, BR | 1 |
| Eksterowicz, J | 1 |
| Sutimantanapi, D | 1 |
| Yuen, N | 1 |
| Metzger, T | 1 |
| Chan, B | 1 |
| Huang, T | 1 |
| Chen, X | 1 |
| Duong, F | 1 |
| Kong, W | 1 |
| Chang, JH | 1 |
| Sun, J | 1 |
| Zavorotinskaya, T | 1 |
| Ye, Q | 1 |
| Junttila, MR | 1 |
| Ndubaku, C | 1 |
| Friedman, LS | 1 |
| Fantin, VR | 1 |
| Sun, D | 1 |
| Fei, P | 1 |
| Xie, Q | 1 |
| Jiang, Y | 1 |
| Feng, H | 1 |
| Chang, Y | 1 |
| Kang, H | 1 |
| Xing, M | 1 |
| Chen, J | 1 |
| Shao, Z | 1 |
| Yuan, C | 1 |
| Wu, Y | 1 |
| Allan, R | 1 |
| Canham, K | 1 |
| Wallace, R | 1 |
| Singh, D | 1 |
| Ward, J | 1 |
| Cooper, A | 1 |
| Newcomb, C | 1 |
| Nammour, S | 1 |
| El Mobadder, M | 1 |
| Maalouf, E | 1 |
| Namour, M | 1 |
| Namour, A | 1 |
| Rey, G | 1 |
| Matamba, P | 1 |
| Matys, J | 1 |
| Zeinoun, T | 1 |
| Grzech-Leśniak, K | 1 |
| Segabinazi Peserico, C | 1 |
| Garozi, L | 1 |
| Zagatto, AM | 1 |
| Machado, FA | 1 |
| Hirth, JM | 1 |
| Dinehart, EE | 1 |
| Lin, YL | 1 |
| Kuo, YF | 1 |
| Nouri, SS | 1 |
| Ritchie, C | 1 |
| Volow, A | 1 |
| Li, B | 2 |
| McSpadden, S | 1 |
| Dearman, K | 1 |
| Kotwal, A | 1 |
| Sudore, RL | 1 |
| Ward, L | 1 |
| Thakur, A | 1 |
| Kondadasula, SV | 1 |
| Ji, K | 1 |
| Schalk, DL | 1 |
| Bliemeister, E | 1 |
| Ung, J | 1 |
| Aboukameel, A | 1 |
| Casarez, E | 1 |
| Sloane, BF | 1 |
| Lum, LG | 1 |
| Xiao, M | 1 |
| Feng, X | 1 |
| Gao, R | 1 |
| Du, B | 1 |
| Brooks, T | 1 |
| Zwirner, J | 1 |
| Hammer, N | 1 |
| Ondruschka, B | 1 |
| Jermy, M | 1 |
| Luengo, A | 1 |
| Marzo, I | 1 |
| Reback, M | 1 |
| Daubit, IM | 1 |
| Fernández-Moreira, V | 1 |
| Metzler-Nolte, N | 1 |
| Gimeno, MC | 1 |
| Tonchev, I | 1 |
| Heberman, D | 1 |
| Peretz, A | 1 |
| Medvedovsky, AT | 1 |
| Gotsman, I | 1 |
| Rashi, Y | 1 |
| Poles, L | 1 |
| Perlman, GY | 1 |
| Danenberg, HD | 1 |
| Beeri, R | 1 |
| Fu, Q | 1 |
| Yang, D | 1 |
| Sarapulova, A | 1 |
| Pang, Q | 1 |
| Meng, Y | 1 |
| Wei, L | 1 |
| Ehrenberg, H | 1 |
| Kim, CC | 1 |
| Jeong, SH | 1 |
| Oh, KH | 1 |
| Nam, KT | 1 |
| Sun, JY | 1 |
| Ning, J | 1 |
| Duan, Z | 1 |
| Kershaw, SV | 1 |
| Rogach, AL | 1 |
| Gao, Z | 1 |
| Wang, T | 1 |
| Li, Q | 1 |
| Cao, T | 1 |
| Guo, L | 1 |
| Fu, Y | 1 |
| Seeger, ZL | 1 |
| Izgorodina, EI | 1 |
| Hue, S | 1 |
| Beldi-Ferchiou, A | 1 |
| Bendib, I | 1 |
| Surenaud, M | 1 |
| Fourati, S | 1 |
| Frapard, T | 1 |
| Rivoal, S | 1 |
| Razazi, K | 1 |
| Carteaux, G | 1 |
| Delfau-Larue, MH | 1 |
| Mekontso-Dessap, A | 1 |
| Audureau, E | 1 |
| de Prost, N | 1 |
| Gao, SS | 1 |
| Duangthip, D | 1 |
| Lo, ECM | 1 |
| Chu, CH | 1 |
| Roberts, W | 1 |
| Rosenheck, RA | 1 |
| Miyake, T | 1 |
| Kimoto, E | 1 |
| Luo, L | 1 |
| Mathialagan, S | 1 |
| Horlbogen, LM | 1 |
| Ramanathan, R | 1 |
| Wood, LS | 1 |
| Johnson, JG | 1 |
| Le, VH | 1 |
| Vourvahis, M | 1 |
| Rodrigues, AD | 1 |
| Muto, C | 1 |
| Furihata, K | 1 |
| Sugiyama, Y | 1 |
| Kusuhara, H | 1 |
| Gong, Q | 1 |
| Song, W | 1 |
| Sun, B | 1 |
| Cao, P | 1 |
| Gu, S | 1 |
| Sun, X | 1 |
| Zhou, G | 1 |
| Toma, C | 1 |
| Khandhar, S | 1 |
| Zalewski, AM | 1 |
| D'Auria, SJ | 1 |
| Tu, TM | 1 |
| Jaber, WA | 1 |
| Cho, J | 2 |
| Suwandaratne, NS | 1 |
| Razek, S | 1 |
| Choi, YH | 1 |
| Piper, LFJ | 1 |
| Watson, DF | 1 |
| Banerjee, S | 1 |
| Xie, S | 1 |
| Lindsay, AP | 1 |
| Bates, FS | 1 |
| Lodge, TP | 1 |
| Hao, Y | 1 |
| Chapovetsky, A | 1 |
| Liu, JJ | 1 |
| Welborn, M | 1 |
| Luna, JM | 1 |
| Do, T | 1 |
| Haiges, R | 1 |
| Miller Iii, TF | 1 |
| Marinescu, SC | 1 |
| Lopez, SA | 1 |
| Compter, I | 1 |
| Eekers, DBP | 1 |
| Hoeben, A | 1 |
| Rouschop, KMA | 1 |
| Reymen, B | 1 |
| Ackermans, L | 1 |
| Beckervordersantforth, J | 1 |
| Bauer, NJC | 1 |
| Anten, MM | 1 |
| Wesseling, P | 1 |
| Postma, AA | 1 |
| De Ruysscher, D | 1 |
| Lambin, P | 1 |
| Qiang, L | 1 |
| Yang, S | 1 |
| Cui, YH | 1 |
| He, YY | 1 |
| Kumar, SK | 1 |
| Jacobus, SJ | 1 |
| Cohen, AD | 1 |
| Weiss, M | 1 |
| Callander, N | 1 |
| Singh, AK | 1 |
| Parker, TL | 1 |
| Menter, A | 1 |
| Parsons, B | 1 |
| Kumar, P | 1 |
| Kapoor, P | 1 |
| Rosenberg, A | 1 |
| Zonder, JA | 1 |
| Faber, E | 1 |
| Lonial, S | 1 |
| Anderson, KC | 1 |
| Richardson, PG | 1 |
| Orlowski, RZ | 1 |
| Wagner, LI | 1 |
| Rajkumar, SV | 1 |
| Li, G | 1 |
| Hou, G | 1 |
| Cui, J | 1 |
| Xie, H | 1 |
| Sun, Z | 1 |
| Fang, Z | 1 |
| Dunstand-Guzmán, E | 1 |
| Hallal-Calleros, C | 1 |
| Hernández-Velázquez, VM | 1 |
| Canales-Vargas, EJ | 1 |
| Domínguez-Roldan, R | 1 |
| Pedernera, M | 1 |
| Peña-Chora, G | 1 |
| Flores-Pérez, I | 1 |
| Kim, MJ | 1 |
| Han, C | 1 |
| White, K | 1 |
| Park, HJ | 1 |
| Ding, D | 1 |
| Boyd, K | 1 |
| Rothenberger, C | 1 |
| Bose, U | 1 |
| Carmichael, P | 1 |
| Linser, PJ | 1 |
| Tanokura, M | 1 |
| Salvi, R | 1 |
| Someya, S | 1 |
| Samuni, A | 1 |
| Goldstein, S | 1 |
| Divya, KP | 1 |
| Dharuman, V | 1 |
| Feng, J | 2 |
| Qian, Y | 1 |
| Cheng, Q | 1 |
| Ma, H | 1 |
| Ren, X | 1 |
| Wei, Q | 1 |
| Pan, W | 1 |
| Guo, J | 1 |
| Situ, B | 1 |
| An, T | 1 |
| Zheng, L | 1 |
| Augusto, S | 1 |
| Ratola, N | 1 |
| Tarín-Carrasco, P | 1 |
| Jiménez-Guerrero, P | 1 |
| Turco, M | 1 |
| Schuhmacher, M | 1 |
| Costa, S | 1 |
| Teixeira, JP | 1 |
| Costa, C | 1 |
| Syed, A | 1 |
| Marraiki, N | 1 |
| Al-Rashed, S | 1 |
| Elgorban, AM | 1 |
| Yassin, MT | 1 |
| Chankhanittha, T | 1 |
| Nanan, S | 1 |
| Sorokina, KN | 1 |
| Samoylova, YV | 1 |
| Gromov, NV | 1 |
| Ogorodnikova, OL | 1 |
| Parmon, VN | 1 |
| Ye, J | 1 |
| Liao, W | 1 |
| Zhang, P | 1 |
| Nabi, M | 1 |
| Cai, Y | 1 |
| Li, F | 1 |
| Alsbou, EM | 1 |
| Omari, KW | 1 |
| Adeosun, WA | 1 |
| Asiri, AM | 1 |
| Marwani, HM | 1 |
| Barral, M | 1 |
| Jemal-Turki, A | 1 |
| Beuvon, F | 1 |
| Soyer, P | 1 |
| Camparo, P | 1 |
| Cornud, F | 1 |
| Atwater, BD | 1 |
| Jones, WS | 1 |
| Loring, Z | 1 |
| Friedman, DJ | 1 |
| Namburath, M | 1 |
| Papirio, S | 1 |
| Moscariello, C | 1 |
| Di Costanzo, N | 1 |
| Pirozzi, F | 1 |
| Alappat, BJ | 1 |
| Sreekrishnan, TR | 1 |
| Volpin, F | 1 |
| Woo, YC | 1 |
| Kim, H | 1 |
| Freguia, S | 1 |
| Jeong, N | 1 |
| Choi, JS | 1 |
| Phuntsho, S | 1 |
| Shon, HK | 1 |
| Domínguez-Zambrano, E | 1 |
| Pedraza-Chaverri, J | 1 |
| López-Santos, AL | 1 |
| Medina-Campos, ON | 1 |
| Cruz-Rivera, C | 1 |
| Bueno-Hernández, F | 1 |
| Espinosa-Cuevas, A | 1 |
| Bulavaitė, A | 1 |
| Dalgediene, I | 1 |
| Michailoviene, V | 1 |
| Pleckaityte, M | 1 |
| Sauerbier, P | 1 |
| Köhler, R | 1 |
| Renner, G | 1 |
| Militz, H | 1 |
| Perez-Cornago, A | 1 |
| Fensom, GK | 1 |
| Andrews, C | 1 |
| Watts, EL | 1 |
| Allen, NE | 1 |
| Martin, RM | 1 |
| Van Hemelrijck, M | 1 |
| Key, TJ | 1 |
| Travis, RC | 1 |
| Teerlink, JR | 1 |
| Diaz, R | 1 |
| Felker, GM | 1 |
| McMurray, JJV | 1 |
| Metra, M | 1 |
| Solomon, SD | 1 |
| Adams, KF | 1 |
| Anand, I | 1 |
| Arias-Mendoza, A | 1 |
| Biering-Sørensen, T | 1 |
| Böhm, M | 1 |
| Bonderman, D | 1 |
| Cleland, JGF | 1 |
| Corbalan, R | 1 |
| Crespo-Leiro, MG | 1 |
| Dahlström, U | 1 |
| Echeverria, LE | 1 |
| Fang, JC | 1 |
| Filippatos, G | 1 |
| Fonseca, C | 1 |
| Goncalvesova, E | 1 |
| Goudev, AR | 1 |
| Howlett, JG | 1 |
| Lanfear, DE | 1 |
| Lund, M | 1 |
| Macdonald, P | 1 |
| Mareev, V | 1 |
| Momomura, SI | 1 |
| O'Meara, E | 1 |
| Ponikowski, P | 1 |
| Ramires, FJA | 1 |
| Serpytis, P | 1 |
| Sliwa, K | 1 |
| Spinar, J | 1 |
| Suter, TM | 1 |
| Tomcsanyi, J | 1 |
| Vandekerckhove, H | 1 |
| Vinereanu, D | 1 |
| Voors, AA | 1 |
| Yilmaz, MB | 1 |
| Zannad, F | 1 |
| Sharpsten, L | 1 |
| Legg, JC | 1 |
| Varin, C | 1 |
| Honarpour, N | 1 |
| Abbasi, SA | 1 |
| Malik, FI | 1 |
| Kurtz, CE | 1 |
| Maciuszek, M | 1 |
| Ortega-Gomez, A | 1 |
| Maas, SL | 1 |
| Perretti, M | 1 |
| Merritt, A | 1 |
| Soehnlein, O | 1 |
| Chapman, TM | 1 |
| Delanghe, S | 1 |
| Delanghe, JR | 1 |
| Speeckaert, R | 1 |
| Van Biesen, W | 1 |
| Speeckaert, MM | 1 |
| De Simone, E | 1 |
| Di Micco, L | 1 |
| La Manna, G | 1 |
| Di Iorio, B | 1 |
| Fu, G | 1 |
| Ćirić Zdravković, S | 1 |
| Pavlović, M | 1 |
| Apostlović, S | 1 |
| Koraćević, G | 1 |
| Šalinger Martinović, S | 1 |
| Stanojević, D | 1 |
| Sokolović, D | 1 |
| Veselinović, AM | 1 |
| Chang, TI | 1 |
| Kang, EW | 1 |
| Lee, YK | 1 |
| Shin, SK | 1 |
| Lesaffre, F | 1 |
| Wynckel, A | 1 |
| Nazeyrollas, P | 1 |
| Rieu, P | 1 |
| Metz, D | 1 |
| Robles, NR | 2 |
| Felix, FJ | 2 |
| Fernandez-Berges, D | 2 |
| Perez-Castán, J | 1 |
| Zaro, MJ | 1 |
| Lozano, L | 2 |
| Alvarez-Palacios, P | 1 |
| Garcia-Trigo, A | 1 |
| Tejero, V | 1 |
| Morcillo, Y | 1 |
| Hidalgo, AB | 1 |
| Kork, F | 1 |
| Jankowski, V | 1 |
| Just, AR | 1 |
| Pfeilschifter, J | 1 |
| Tepel, M | 1 |
| Zidek, W | 1 |
| Jankowski, J | 1 |
| Boere, E | 1 |
| Birkenhäger, TK | 1 |
| Groenland, TH | 1 |
| van den Broek, WW | 1 |
| Mansell, H | 1 |
| Elmoselhi, H | 1 |
| Shoker, A | 1 |
| Miranda, I | 1 |
| Macías, JF | 1 |
| Courand, PY | 1 |
| Lesiuk, C | 1 |
| Milon, H | 1 |
| Defforges, A | 1 |
| Fouque, D | 2 |
| Harbaoui, B | 1 |
| Lantelme, P | 1 |
| Xiao, F | 1 |
| Burns, KD | 1 |
| Nilsson, SE | 1 |
| Fransson, E | 1 |
| Brismar, K | 1 |
| Kuhlmann, MK | 1 |
| Almeida, FA | 1 |
| Machado, FC | 1 |
| Moura, JA | 1 |
| Guimarães, AC | 1 |
| Švíglerová, J | 1 |
| Kuncová, J | 1 |
| Nalos, L | 1 |
| Tonar, Z | 1 |
| Rajdl, D | 1 |
| Stengl, M | 1 |
| Hirata, N | 1 |
| Miyashita, R | 1 |
| Watanabe, A | 1 |
| Yamakage, M | 1 |
| Rajković, MG | 1 |
| Rumora, L | 1 |
| Juretić, D | 1 |
| Grubisić, TZ | 1 |
| Flegar-Mestrić, Z | 1 |
| Vrkić, N | 1 |
| Sinjeri, Z | 1 |
| Barisić, K | 1 |
| Fox, CJ | 1 |
| Kaye, AD | 1 |
| Ching, CT | 1 |
| Chou, TR | 1 |
| Sun, TP | 1 |
| Huang, SY | 1 |
| Shieh, HL | 1 |
| López Gómez, JM | 1 |
| Sacristán Enciso, B | 1 |
| Micó, M | 1 |
| Arias Meneses, F | 1 |
| de Sande Medel, F | 1 |
| Alejo, S | 1 |
| Schroeder, MA | 1 |
| Clarke, K | 1 |
| Neubauer, S | 1 |
| Tyler, DJ | 1 |
| Millán-Calenti, JC | 1 |
| Sánchez, A | 1 |
| Lorenzo-López, L | 1 |
| Maseda, A | 1 |
| Neirynck, N | 1 |
| Vanholder, R | 1 |
| Schepers, E | 1 |
| Eloot, S | 1 |
| Pletinck, A | 1 |
| Glorieux, G | 1 |
| Moreira, EL | 1 |
| de Oliveira, J | 1 |
| Dutra, MF | 1 |
| Santos, DB | 1 |
| Gonçalves, CA | 1 |
| Goldfeder, EM | 1 |
| de Bem, AF | 1 |
| Prediger, RD | 1 |
| Aschner, M | 1 |
| Farina, M | 1 |
| Kawamoto, O | 1 |
| Michiue, T | 1 |
| Ishikawa, T | 1 |
| Maeda, H | 1 |
| de Oliveira, EP | 1 |
| Moreto, F | 1 |
| Silveira, LV | 1 |
| Burini, RC | 1 |
| WALTERS, MN | 1 |
| Azadbakht, L | 1 |
| Shakerhosseini, R | 1 |
| Atabak, S | 1 |
| Jamshidian, M | 1 |
| Mehrabi, Y | 1 |
| Esmaill-Zadeh, A | 1 |
| Zoccali, C | 1 |
| Mallamaci, F | 1 |
| Tripepi, G | 1 |
| Benedetto, FA | 1 |
| Parlongo, S | 1 |
| Cutrupi, S | 1 |
| Iellamo, D | 1 |
| Bonanno, G | 1 |
| Rapisarda, F | 1 |
| Fatuzzo, P | 1 |
| Seminara, G | 1 |
| Cataliotti, A | 1 |
| Malatino, LS | 1 |
| Fung, JW | 1 |
| Szeto, CC | 1 |
| Chan, WW | 1 |
| Kum, LC | 1 |
| Chan, AK | 1 |
| Wong, JT | 1 |
| Wu, EB | 1 |
| Yip, GW | 1 |
| Chan, JY | 1 |
| Yu, CM | 1 |
| Woo, KS | 1 |
| Sanderson, JE | 1 |
| Briscoe, TA | 1 |
| Rehn, AE | 1 |
| Dieni, S | 1 |
| Duncan, JR | 1 |
| Wlodek, ME | 1 |
| Owens, JA | 1 |
| Rees, SM | 1 |
| Kielstein, JT | 1 |
| Böger, RH | 1 |
| Bode-Böger, SM | 1 |
| Martens-Lobenhoffer, J | 1 |
| Lonnemann, G | 1 |
| Frölich, JC | 1 |
| Haller, H | 1 |
| Fliser, D | 1 |
| Kornberg, A | 1 |
| Küpper, B | 1 |
| Hommann, M | 1 |
| Scheele, J | 1 |
| Rao, M | 1 |
| Guo, D | 1 |
| Perianayagam, MC | 1 |
| Tighiouart, H | 1 |
| Jaber, BL | 1 |
| Pereira, BJ | 1 |
| Balakrishnan, VS | 1 |
| Chauveau, P | 1 |
| Nguyen, H | 1 |
| Combe, C | 1 |
| Chêne, G | 1 |
| Azar, R | 1 |
| Cano, N | 1 |
| Canaud, B | 1 |
| Laville, M | 1 |
| Leverve, X | 1 |
| Roth, H | 1 |
| Aparicio, M | 1 |
| Schulman, G | 1 |
| Grzegorzewska, AE | 1 |
| Shinaberger, CS | 1 |
| Kilpatrick, RD | 1 |
| Regidor, DL | 1 |
| McAllister, CJ | 1 |
| Greenland, S | 1 |
| Kopple, JD | 1 |
| Kalantar-Zadeh, K | 1 |
| Gupta, S | 1 |
| Sarotra, P | 1 |
| Aggarwal, R | 1 |
| Dutta, N | 1 |
| Agnihotri, N | 1 |
| Durante, W | 1 |
| Johnson, FK | 1 |
| Johnson, RA | 1 |
| Shah, SV | 1 |
| Apostolov, EO | 1 |
| Ok, E | 1 |
| Basnakian, AG | 1 |
| Degoulet, P | 1 |
| Legrain, M | 1 |
| Réach, I | 1 |
| Aimé, F | 1 |
| Devriés, C | 1 |
| Rojas, P | 1 |
| Jacobs, C | 1 |
| Oreopoulos, DG | 1 |
| Davidson, RJ | 1 |
| How, J | 1 |
| Lessels, S | 1 |
| Marangoni, R | 1 |
| Savino, R | 1 |
| Colombo, R | 1 |
| Cimino, R | 1 |
| Civardi, F | 1 |
| Swaminathan, R | 1 |
| Ho, CS | 1 |
| Chu, LM | 1 |
| Donnan, S | 1 |
| Brunner, L | 1 |
| Heisig, B | 1 |
| Scheler, F | 1 |
| Stapenhorst, K | 1 |
| Tauschke, D | 1 |
| Baumgarten, C | 1 |
| Hoffmeister, HE | 1 |
| Kirchhoff, PG | 1 |
| Rastan, H | 1 |
| Regensburger, D | 1 |
| Stunkat, R | 1 |
| de Vivie, R | 1 |
| Koncz, J | 1 |
| Dobbelstein, H | 1 |
| Orlowski, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Pulmonary Pressure Guided Therapy in Stable Outpatients With Advanced Heart Failure - A Randomized Controlled Clinical Trial[NCT05284955] | Phase 4 | 60 participants (Anticipated) | Interventional | 2023-03-02 | Recruiting | ||
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)[NCT02929329] | Phase 3 | 8,256 participants (Actual) | Interventional | 2017-01-06 | Completed | ||
| An Observational Cross-sectional Study to Compare Carbamylated High-density Lipoprotein Levels Among Normal Subjects, Type 2 Diabetes Mellitus Patients With and Without Coronary Heart Disease.[NCT04390711] | 282 participants (Actual) | Observational | 2018-09-01 | Completed | |||
| Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study: An Investigator Initiated Study[NCT01116947] | 108 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The Kansas City Cardiomyopathy Questionnaire is a self-administered questionnaire with a 2-week recall period that includes 23 items that map to 7 domains: symptom frequency; symptom burden; symptom stability; physical limitations; social limitations; quality of life; and self-efficacy (the patient's understanding of how to manage their heart failure). The symptom frequency and symptom burden domains are merged into a total symptom score. Scores are represented on a 0-to-100-point scale, where lower scores represent more frequent and severe symptoms and scores of 100 indicate no symptoms.~The change from baseline in KCCQ TSS was analyzed separately for each randomization setting (inpatient and outpatient).~Least squares means are from the mixed model which includes baseline total symptom score value, region, baseline eGFR, scheduled visit, treatment group and interaction of treatment with scheduled visit as covariates." (NCT02929329)
Timeframe: Baseline and Week 24
| Intervention | scores on a scale (Least Squares Mean) |
|---|---|
| Placebo: Oupatients | 6.29 |
| Omecamtiv Mecarbil: Outpatients | 5.83 |
| Placebo: Inpatients | 21.15 |
| Omecamtiv Mecarbil: Inpatients | 23.65 |
"All events were adjudicated by an independent external clinical-events committee at the Duke Clinical Research Institute, using standardized definitions based on the recent ACC/AHA standards for endpoint definitions in cardiovascular clinical trials.~Time to all-cause death was analyzed using Kaplan-Meier methods. Since the median was not calculated, the percentage of participants with an event are reported. Events that occurred up to the earliest of last confirmed survival status date or analysis cut-off date (07 August 2020) are included." (NCT02929329)
Timeframe: From randomization up to earliest of last confirmed survival status date or analysis cut-off date (07 August 2020); the overall median duration of follow-up was 21.8 months up to a maximum of 42 months.
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 25.9 |
| Omecamtiv Mecarbil | 25.9 |
"Cardiovascular death includes acute myocardial infarction (MI), sudden cardiac death, death due to heart failure, death due to stroke, death due to cardiovascular (CV) procedures, death due to CV hemorrhage, and death due to other CV causes.~All deaths were adjudicated by an independent external clinical-events committee at the Duke Clinical Research Institute, using standardized definitions based on the recent ACC/AHA standards for endpoint definitions in cardiovascular clinical trials.~Time to cardiovascular death was analyzed using Kaplan-Meier methods. Since the median was not calculated, the percentage of participants with a positively adjudicated event during the study is reported." (NCT02929329)
Timeframe: From randomization to up to earliest of last confirmed survival status date or analysis cut-off date (07 August 2020); the overall median duration of follow-up was 21.8 months up to a maximum of 42 months.
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 19.4 |
| Omecamtiv Mecarbil | 19.6 |
"The primary outcome was a composite of a heart-failure (HF) event or cardiovascular (CV) death, whichever occurred first, in a time-to-event analysis.~A heart-failure event was defined as an urgent clinic visit, emergency department visit, or hospitalization for subjectively and objectively worsening heart failure leading to treatment intensification beyond a change in oral diuretic therapy.~All deaths and HF events were adjudicated by an independent external clinical events committee (CEC) at the Duke Clinical Research Institute, using standardized definitions based on the recent American College of Cardiology/American Heart Association (ACC/AHA) standards for endpoint definitions in cardiovascular clinical trials.~Time to cardiovascular death or first HF event was analyzed using Kaplan-Meier (KM) methods. Since the median was not calculated, the percentage of participants with a positively adjudicated event during the study is reported." (NCT02929329)
Timeframe: From randomization to up to earliest of last confirmed survival status date or analysis cut-off date (07 August 2020); the overall median duration of follow-up was 21.8 months up to a maximum of 42 months.
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 39.1 |
| Omecamtiv Mecarbil | 37.0 |
"A HF hospitalization is defined as an event that met all of the following criteria:~The participant was admitted to the hospital with a primary diagnosis of HF;~The length of stay in the hospital extended for at least 24 hours;~The participant exhibited documented new or worsening symptoms due to HF on presentation;~The participant had objective evidence of new or worsening HF;~The participant received initiation or intensification of treatment specifically for HF, including an intravenous diuretic or vasoactive agent, mechanical or surgical intervention, or mechanical fluid removal.~Events were adjudicated by an independent external CEC at the Duke Clinical Research Institute using standardized definitions based on the ACC/AHA standards for endpoint definitions in CV clinical trials.~Time to first HF hospitalization was analyzed using KM methods. Since the median was not calculated, the percentage of participants with a positively adjudicated event is reported." (NCT02929329)
Timeframe: From randomization to up to earliest of last confirmed survival status date or analysis cut-off date (07 August 2020); the overall median duration of follow-up was 21.8 months up to a maximum of 42 months.
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 28.7 |
| Omecamtiv Mecarbil | 27.7 |
11 reviews available for urea and Cardiovascular Diseases
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Mechanisms and consequences of carbamoylation.
Topics: Biomarkers; Cardiovascular Diseases; Erythropoietin; Hemoglobins; Humans; Kidney Failure, Chronic; P | 2017 |
[Protein carbamylation: what it is and why it concerns nephrologists].
Topics: Alzheimer Disease; Amino Acids; Amyloidosis; Anemia, Sickle Cell; Animals; Cardiovascular Diseases; | 2018 |
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; | 2014 |
Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Topics: Anticoagulants; Ascitic Fluid; Cardiovascular Diseases; Combined Modality Therapy; Creatinine; Diffu | 2010 |
Cardiovascular pharmacology: an update.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Diastole; Heart Failure; Humans; Hydrazones | 2010 |
Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.
Topics: Animals; Bicarbonates; Carbon Isotopes; Cardiomyopathies; Cardiovascular Diseases; Diagnostic Techni | 2011 |
An update on uremic toxins.
Topics: beta 2-Microglobulin; Biomarkers; Cardiovascular Diseases; Cresols; Dialysis Solutions; Fibroblast G | 2013 |
Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Topics: Animals; Arginase; Arginine; Cardiovascular Diseases; Cell Proliferation; Collagen; Endothelium, Vas | 2007 |
The optimization of continuous ambulatory peritoneal dialysis.
Topics: Blood Urea Nitrogen; Cardiovascular Diseases; Creatinine; Glomerulonephritis, Membranoproliferative; | 1999 |
[Pathogenesis of uremia].
Topics: Acidosis; Aminobenzoates; Ammonia; Anemia; Animals; Butyrates; Cardiovascular Diseases; Central Nerv | 1971 |
10 trials available for urea and Cardiovascular Diseases
| Article | Year |
|---|---|
Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: a multi-center prospective randomized controlled study.
Topics: Anemia; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Erythropoietin; Fructosamine | 2022 |
Vitamin D
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; C-Reactive Protein; Cardiovasc | 2021 |
Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial.
Topics: Adult; Anthropometry; Bifidobacterium; Bifidobacterium animalis; Biomarkers; Blood Glucose; Blood Pr | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Myosins; Cardiotonic Agents; Cardiovascular Diseases; Female; Heart | 2021 |
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Myosins; Cardiotonic Agents; Cardiovascular Diseases; Female; Heart | 2021 |
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Myosins; Cardiotonic Agents; Cardiovascular Diseases; Female; Heart | 2021 |
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiac Myosins; Cardiotonic Agents; Cardiovascular Diseases; Female; Heart | 2021 |
Low-dose continuous infusion of landiolol can reduce adrenergic response during tracheal intubation in elderly patients with cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, General; Autonomic Nervous System Diseases; Blood Pre | 2010 |
Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
Topics: Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephro | 2003 |
Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiovascular Diseases; Comorbidity; Contrast Media; Cor | 2004 |
Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction.
Topics: Adult; Aged; Blood Pressure; Calcineurin Inhibitors; Cardiovascular Diseases; Cholesterol; Creatinin | 2005 |
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta 2-Microglobulin; Biomarkers; Cardiovascular Disease | 2005 |
41 other studies available for urea and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Physiological and Pathological Urea Concentrations on Human Microvascular Endothelial Cells.
Topics: Cardiovascular Diseases; Endothelial Cells; Humans; Proteins; Proteomics; Renal Dialysis; Renal Insu | 2022 |
Urea level is an independent predictor of mortality in patients with severe aortic valve stenosis.
Topics: Age Factors; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Cardiovascular Diseases; | 2020 |
Asymmetric dimethylarginine compartmental behavior during high-flux hemodialysis.
Topics: Adult; Arginine; Cardiovascular Diseases; Creatinine; Humans; Kidney Failure, Chronic; Male; Middle | 2020 |
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.
Topics: Adult; Aged; Aspartate Aminotransferases; Biomarkers, Tumor; Blood Glucose; Blood Proteins; Cardiova | 2020 |
Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cell Adhesion; Cyclopentanes; Dose | 2021 |
The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Cardi | 2018 |
Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition-In silico approach.
Topics: Cardiovascular Diseases; Computer Simulation; Computer-Aided Design; Dose-Response Relationship, Dru | 2019 |
Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient.
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Female; Humans; Kaplan | 2013 |
Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Disease-Free Survival; Female; Glomeru | 2013 |
The HUGE formula (hematocrit, urea and gender): association with cardiovascular risk.
Topics: Adult; Aged; Albuminuria; Algorithms; Arterial Occlusive Diseases; Cardiovascular Diseases; Cerebrov | 2013 |
Oxidized low-density lipoprotein in postmenopausal women.
Topics: Atherosclerosis; Biomarkers; Blood Chemical Analysis; Cardiovascular Diseases; Carotid Intima-Media | 2014 |
Association between circulating thrombopoietin levels and cardiovascular risk prediction scores in renal transplant recipients.
Topics: Adult; Age Factors; Aged; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Creatinine; Fem | 2015 |
The H.U.G.E. Formula (Hematocrit, Urea, Sex) for Screening Chronic Kidney Disease (CKD) in an Age-Stratified General Population.
Topics: Adult; Age Distribution; Age Factors; Aged; Aging; Albuminuria; Anthropometry; Cardiovascular Diseas | 2015 |
Association Between Protein Intake and Mortality in Hypertensive Patients Without Chronic Kidney Disease in the OLD-HTA Cohort.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Cardiovascular Diseases; Cause o | 2016 |
Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2).
Topics: Angiotensin-Converting Enzyme 2; Animals; Biological Assay; Cardiovascular Diseases; Creatinine; Flu | 2017 |
Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: An 8-year prospective study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cystatins; Diabete | 2009 |
Global and cardiovascular mortality and risk factors in patients under hemodialysis treatment.
Topics: Age Factors; Blood Glucose; Brazil; Cardiovascular Diseases; Cause of Death; Epidemiologic Methods; | 2010 |
Cardiovascular parameters in rat model of chronic renal failure induced by subtotal nephrectomy.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atropine; Biomarkers; Blood Pressure; Cardi | 2010 |
Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis.
Topics: Aged; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cardiovascular Diseases; Creatinine; Fema | 2010 |
Simultaneous, noninvasive, and transdermal extraction of urea and homocysteine by reverse iontophoresis.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; In Vitro Techniques; Iontophoresis; Kidney D | 2011 |
Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages.
Topics: Adult; Aged; Aged, 80 and over; Aging; Albuminuria; Biomarkers; Cardiovascular Diseases; Chronic Dis | 2011 |
Laboratory values in a Spanish population of older adults: a comparison with reference values from younger adults.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholestero | 2012 |
Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease?
Topics: Animals; Anticholesteremic Agents; Behavior, Animal; Biomarkers; Cardiovascular Diseases; Cerebellum | 2012 |
Comprehensive evaluation of pericardial biochemical markers in death investigation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Alcoholic Intoxication; Asphyxia; Biomarkers; | 2013 |
Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; Body Composition; Body Ma | 2013 |
STUDIES ON THE EXOCRINE PANCREAS. I. NONSPECIFIC PANCREATIC DUCTULAR ECTASIA.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Blood; Cardiovascular Diseases; Cholecystitis; Defic | 1964 |
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Epinephrine; Female; Follow-Up Studies; Humans; In | 2003 |
Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency.
Topics: Adrenal Glands; Animals; Aorta; Arteries; Body Weight; Cardiovascular Diseases; Chlorides; Chronic D | 2004 |
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding.
Topics: Arginine; Cardiovascular Diseases; Creatine; Female; Humans; In Vitro Techniques; Kidney Failure, Ch | 2004 |
Dialyzer membrane permeability and survival in hemodialysis patients.
Topics: Aged; Bicarbonates; Body Composition; Body Mass Index; Cardiovascular Diseases; Cause of Death; Chol | 2005 |
Daily hemodialysis: the time has come?--Con.
Topics: Appointments and Schedules; Biomarkers; Cardiovascular Diseases; Hospitalization; Humans; Hypoalbumi | 2005 |
[Which factors determine survival of patients on regular dialysis treatment?].
Topics: Adult; Age Factors; Aged; Body Weight; Cardiovascular Diseases; Comorbidity; Humans; Kidney Failure, | 2005 |
Longitudinal associations between dietary protein intake and survival in hemodialysis patients.
Topics: Aged; Cardiovascular Diseases; Dietary Proteins; Female; Humans; Longitudinal Studies; Male; Middle | 2006 |
Role of oxidative stress in celecoxib-induced renal damage in wistar rats.
Topics: Animals; Biomarkers; Cardiovascular Diseases; Catalase; Celecoxib; Creatinine; Cyclooxygenase Inhibi | 2007 |
Novel mechanisms in accelerated atherosclerosis in kidney disease.
Topics: Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cell Division; Cell Survival; Cells, Cultured; | 2008 |
Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; | 1982 |
Acquired stomatocytosis: its prevalence of significance in routine haematology.
Topics: Adolescent; Adult; Alcoholism; Anemia, Hemolytic; Cardiovascular Diseases; Drug-Related Side Effects | 1977 |
Short time treatment with high-efficiency paired filtration dialysis for chronic renal failure.
Topics: Adult; Aged; Anuria; beta 2-Microglobulin; Cardiovascular Diseases; Creatinine; Hemofiltration; Huma | 1992 |
Relation between plasma creatinine and body size.
Topics: Adult; Age Factors; Aged; Anthropometry; Body Weight; Cardiovascular Diseases; Creatinine; Female; H | 1986 |
[Causes of acute kidney failure following surgery using the heart-lung machine. (Report on 43 out of 1500 case histories of patients operated during extracorporeal circulation)].
Topics: Acute Kidney Injury; Adolescent; Adult; Anuria; Blood Pressure; Cardiac Surgical Procedures; Cardiov | 1972 |
Prerenal uremia in chronic renal diseases. I. Prerenal uremia due to circulatory failure.
Topics: Adult; Cardiac Glycosides; Cardiovascular Diseases; Chronic Disease; Female; Glomerular Filtration R | 1969 |